Identification of a robust gene signature that predicts breast cancer outcome in independent data sets
<p>Abstract</p> <p>Background</p> <p>Breast cancer is a heterogeneous disease, presenting with a wide range of histologic, clinical, and genetic features. Microarray technology has shown promise in predicting outcome in these patients.</p> <p>Methods</p&g...
Main Authors: | Estep Anne LH, Chen Yunn-Yi, Hwang E Shelley, Moore Dan H, DeVries Sandy, Blaveri Ekaterina, Korkola James E, Chew Karen L, Jensen Ronald H, Waldman Frederic M |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-04-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/7/61 |
Similar Items
-
Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma <it>in situ</it>
by: Shim Veronica, et al.
Published: (2009-08-01) -
Phenotypic robustness and the assortativity signature of human transcription factor networks.
by: Dov A Pechenick, et al.
Published: (2014-08-01) -
Robust signature verification based on multiple classifiers /
by: Marzuki Khalid, 1959-2012, author, et al.
Published: (2009) -
A robust gene expression signature for NASH in liver expression data
by: Yehudit Hasin-Brumshtein, et al.
Published: (2022-02-01) -
Design of robust power system stabilizers for Iraqi power network
by: Almurib, H.A.F., et al.
Published: (2011)